AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) stock Average True Range

ATR:

$0.89-$0.01(-0.72%)
December 9, 2025

Summary

  • As of today, AMLX stock average true range is $0.89, with the most recent change of -$0.01 (-0.72%) on December 9, 2025.
  • Over the past year, AMLX stock ATR has increased by +$0.46 (+107.33%).

Performance

AMLX ATR Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Range

OtherAMLXtechnical indicators

AMLX ATR Trends

PeriodPeriodATRATRPricePrice200-Day SMA200-Day SMASPXSPX
1D1 Day-0.7%-3.1%+0.6%-0.1%
1M1 Month+8.3%+7.5%+14.8%+1.7%
3M3 Months+84.3%+26.0%+58.5%+5.0%
6M6 Months+144.6%+143.4%+107.4%+13.9%
YTDYTD+182.5%+250.3%+182.8%+16.3%
1Y1 Year+107.3%+171.3%+132.4%+13.0%
5Y5 Years---+86.3%

AMLX ATR Highs & Lows

PeriodPeriodHighHighCurrent vs Highvs HighLowLowCurrent vs Lowvs Low
1M1-Month$0.98-8.9%$0.81+11.1%
3M3-Month$1.01-11.1%$0.49+84.3%
6M6-Month$1.01-11.1%$0.36+151.4%
1Y1-Year$1.01-11.1%$0.26+242.3%
3Y3-Year$2.45-63.6%$0.10+796.9%
5Y5-Year$3.61-75.3%$0.10+796.9%
All-TimeAll-Time$3.61-75.3%$0.10+796.9%

AMLX ATR History

DateValue
2025
$0.89(+182.5%)
2024
$0.32(-58.8%)
DateValue
2023
$0.77(-61.5%)
2022
$1.99

FAQ

  • What is Amylyx Pharmaceuticals, Inc. average true range?
  • What is the all-time high ATR for Amylyx Pharmaceuticals, Inc.?
  • What is AMLX average true range year-to-date change?
  • What is Amylyx Pharmaceuticals, Inc. ATR year-on-year change?

What is Amylyx Pharmaceuticals, Inc. average true range?

The current ATR of AMLX is $0.89

What is the all-time high ATR for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high average true range is $3.61

What is AMLX average true range year-to-date change?

Amylyx Pharmaceuticals, Inc. average true range has changed by +$0.58 (+182.53%) since the beginning of the year

What is Amylyx Pharmaceuticals, Inc. ATR year-on-year change?

Over the past year, AMLX average true range has changed by +$0.46 (+107.33%)
On this page